PanelApp (test)

Activity

Filter

Cancel
Date Panel Item Activity
116 actions
Wilms Tumour Predisposition v0.39 Zornitza Stark HPO terms changed from to Wilms tumour, MONDO:0006058
List of related panels changed from to Wilms tumour; MONDO:0006058
Wilms Tumour Predisposition v0.38 FBXW7 Zornitza Stark reviewed gene: FBXW7: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Wilms tumour, hereditary, MONDO:0003321, FBXW7-related; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.38 FBXW7 Zornitza Stark Phenotypes for gene: FBXW7 were changed from Wilms tumour to Wilms tumour, hereditary, MONDO:0003321, FBXW7-related
Wilms Tumour Predisposition v0.37 FBXW7 Zornitza Stark Publications for gene: FBXW7 were set to PMID: 30885698; PMID: 26482194
Wilms Tumour Predisposition v0.36 FBXW7 Zornitza Stark Classified gene: FBXW7 as Amber List (moderate evidence)
Wilms Tumour Predisposition v0.36 FBXW7 Zornitza Stark Gene: fbxw7 has been classified as Amber List (Moderate Evidence).
Wilms Tumour Predisposition v0.35 FBXW7 Nicola Poplawski reviewed gene: FBXW7: Rating: RED; Mode of pathogenicity: None; Publications: 35395208, 30885698, 28572459, 20332316; Phenotypes: ; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.35 DIS3L2 Zornitza Stark Marked gene: DIS3L2 as ready
Wilms Tumour Predisposition v0.35 DIS3L2 Zornitza Stark Gene: dis3l2 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.35 DIS3L2 Zornitza Stark Phenotypes for gene: DIS3L2 were changed from to Wilms tumour, MONDO:0006058, DIS3L2-related
Wilms Tumour Predisposition v0.34 DIS3L2 Zornitza Stark Publications for gene: DIS3L2 were set to
Wilms Tumour Predisposition v0.33 DIS3L2 Zornitza Stark Mode of inheritance for gene: DIS3L2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.32 DIS3L2 Zornitza Stark reviewed gene: DIS3L2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Wilms tumour, MONDO:0006058, DIS3L2-related; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.32 DIS3L2 Laura Raiti changed review comment from: 5 unrelated patients in an unselected cohort of children between 2015 - 2020 identified to have germline heterozygous pathogenic variant in DIS3L2 (two truncating variants, 3 deletions of exon 9). 4 of 5 had a second somatic hit in Wilms Tumour tissue.; to: 5 unrelated patients in an unselected cohort of children between 2015 - 2020 identified to have germline heterozygous pathogenic variant in DIS3L2 (two truncating variants, 3 deletions of exon 9). 4 of 5 had a second somatic hit in Wilms Tumour tissue.
Wilms Tumour Predisposition v0.32 DIS3L2 Laura Raiti reviewed gene: DIS3L2: Rating: ; Mode of pathogenicity: None; Publications: 35230882; Phenotypes: Wilms Tumour; Mode of inheritance: None
Wilms Tumour Predisposition v0.32 CTCF Zornitza Stark Marked gene: CTCF as ready
Wilms Tumour Predisposition v0.32 CTCF Zornitza Stark Gene: ctcf has been classified as Red List (Low Evidence).
Wilms Tumour Predisposition v0.32 CTCF Zornitza Stark Classified gene: CTCF as Red List (low evidence)
Wilms Tumour Predisposition v0.32 CTCF Zornitza Stark Gene: ctcf has been classified as Red List (Low Evidence).
Wilms Tumour Predisposition v0.31 CTCF Manny Jacobs gene: CTCF was added
gene: CTCF was added to Wilms Tumour Predisposition. Sources: Literature
Mode of inheritance for gene: CTCF was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Publications for gene: CTCF were set to PMID: 31239556; 23746550; 31239556; 35459888
Phenotypes for gene: CTCF were set to autosomal dominant intellectual developmental disorder 21, MONDO:0014213 (MIM# 615502)
Penetrance for gene: CTCF were set to unknown
Review for gene: CTCF was set to RED
Added comment: PMID: 35459888
1 individual with delayed intellectual development and bilateral wilms tumour Dx at 2 years old.
Sources: Literature
Wilms Tumour Predisposition v0.31 TRIM28 Zornitza Stark Phenotypes for gene: TRIM28 were changed from Wilm's tumour to Wilms tumour, MONDO:0006058, TRIM28-related
Wilms Tumour Predisposition v0.30 TRIM28 Zornitza Stark edited their review of gene: TRIM28: Changed phenotypes: Wilms tumour, MONDO:0006058, TRIM28-related
Wilms Tumour Predisposition v0.30 REST Zornitza Stark Marked gene: REST as ready
Wilms Tumour Predisposition v0.30 REST Zornitza Stark Gene: rest has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.30 REST Zornitza Stark Phenotypes for gene: REST were changed from to {Wilms tumor 6, susceptibility to}, MIM# 616806
Wilms Tumour Predisposition v0.29 REST Zornitza Stark Publications for gene: REST were set to
Wilms Tumour Predisposition v0.28 REST Zornitza Stark Mode of inheritance for gene: REST was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.27 REST Zornitza Stark reviewed gene: REST: Rating: GREEN; Mode of pathogenicity: None; Publications: 26551668, 34308104; Phenotypes: {Wilms tumor 6, susceptibility to}, MIM# 616806; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.27 PIK3CA Zornitza Stark Marked gene: PIK3CA as ready
Wilms Tumour Predisposition v0.27 PIK3CA Zornitza Stark Gene: pik3ca has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.27 PIK3CA Zornitza Stark Mode of inheritance for gene: PIK3CA was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.26 PIK3CA Zornitza Stark Phenotypes for gene: PIK3CA were changed from to Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, MIM# 602501
Wilms Tumour Predisposition v0.25 PIK3CA Zornitza Stark Tag somatic tag was added to gene: PIK3CA.
Wilms Tumour Predisposition v0.25 PIK3CA Zornitza Stark reviewed gene: PIK3CA: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, MIM# 602501; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.25 GPC4 Zornitza Stark Marked gene: GPC4 as ready
Wilms Tumour Predisposition v0.25 GPC4 Zornitza Stark Gene: gpc4 has been classified as Red List (Low Evidence).
Wilms Tumour Predisposition v0.25 GPC4 Zornitza Stark Classified gene: GPC4 as Red List (low evidence)
Wilms Tumour Predisposition v0.25 GPC4 Zornitza Stark Gene: gpc4 has been classified as Red List (Low Evidence).
Wilms Tumour Predisposition v0.24 GPC4 Zornitza Stark reviewed gene: GPC4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None
Wilms Tumour Predisposition v0.24 GPC3 Zornitza Stark Marked gene: GPC3 as ready
Wilms Tumour Predisposition v0.24 GPC3 Zornitza Stark Gene: gpc3 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.24 GPC3 Zornitza Stark Phenotypes for gene: GPC3 were changed from Simpson-Golabi-Behmel syndrome, type 1, MIM# 312870 to Simpson-Golabi-Behmel syndrome, type 1, MIM# 312870
Wilms Tumour Predisposition v0.24 GPC3 Zornitza Stark Phenotypes for gene: GPC3 were changed from to Simpson-Golabi-Behmel syndrome, type 1, MIM# 312870
Wilms Tumour Predisposition v0.23 GPC3 Zornitza Stark Mode of inheritance for gene: GPC3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females
Wilms Tumour Predisposition v0.22 GPC3 Zornitza Stark reviewed gene: GPC3: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Simpson-Golabi-Behmel syndrome, type 1, MIM# 312870; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females
Wilms Tumour Predisposition v0.22 CTR9 Zornitza Stark Marked gene: CTR9 as ready
Wilms Tumour Predisposition v0.22 CTR9 Zornitza Stark Gene: ctr9 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.22 CTR9 Zornitza Stark Phenotypes for gene: CTR9 were changed from to Familial Wilms tumour, MONDO:0006058, CTR9-related
Wilms Tumour Predisposition v0.21 CTR9 Zornitza Stark Publications for gene: CTR9 were set to
Wilms Tumour Predisposition v0.20 CTR9 Zornitza Stark Mode of inheritance for gene: CTR9 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.19 CTR9 Zornitza Stark reviewed gene: CTR9: Rating: GREEN; Mode of pathogenicity: None; Publications: 25099282, 29292210; Phenotypes: Familial Wilms tumour, MONDO:0006058, CTR9-related; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.19 CDC73 Zornitza Stark Marked gene: CDC73 as ready
Wilms Tumour Predisposition v0.19 CDC73 Zornitza Stark Gene: cdc73 has been classified as Amber List (Moderate Evidence).
Wilms Tumour Predisposition v0.19 CDC73 Zornitza Stark Phenotypes for gene: CDC73 were changed from to Hyperparathyroidism-jaw tumor syndrome, MIM# 145001
Wilms Tumour Predisposition v0.18 CDC73 Zornitza Stark Publications for gene: CDC73 were set to
Wilms Tumour Predisposition v0.17 CDC73 Zornitza Stark Mode of inheritance for gene: CDC73 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.16 CDC73 Zornitza Stark Classified gene: CDC73 as Amber List (moderate evidence)
Wilms Tumour Predisposition v0.16 CDC73 Zornitza Stark Gene: cdc73 has been classified as Amber List (Moderate Evidence).
Wilms Tumour Predisposition v0.15 CDC73 Zornitza Stark reviewed gene: CDC73: Rating: AMBER; Mode of pathogenicity: None; Publications: 7912571; Phenotypes: Hyperparathyroidism-jaw tumor syndrome, MIM# 145001; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Wilms Tumour Predisposition v0.15 TRIM37 Zornitza Stark Marked gene: TRIM37 as ready
Wilms Tumour Predisposition v0.15 TRIM37 Zornitza Stark Gene: trim37 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.15 TRIM37 Zornitza Stark Phenotypes for gene: TRIM37 were changed from to Mulibrey nanism, MIM# 253250
Wilms Tumour Predisposition v0.14 TRIM37 Zornitza Stark Publications for gene: TRIM37 were set to
Wilms Tumour Predisposition v0.13 TRIM37 Zornitza Stark Mode of inheritance for gene: TRIM37 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
Wilms Tumour Predisposition v0.12 TRIM37 Zornitza Stark reviewed gene: TRIM37: Rating: GREEN; Mode of pathogenicity: None; Publications: 34309235, 19334051, 17100991; Phenotypes: Mulibrey nanism, MIM# 253250; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Wilms Tumour Predisposition v0.12 Bryony Thompson Panel types changed to Victorian Clinical Genetics Services; Royal Melbourne Hospital
Wilms Tumour Predisposition v0.11 NYNRIN Zornitza Stark Marked gene: NYNRIN as ready
Wilms Tumour Predisposition v0.11 NYNRIN Zornitza Stark Gene: nynrin has been classified as Amber List (Moderate Evidence).
Wilms Tumour Predisposition v0.11 NYNRIN Zornitza Stark Phenotypes for gene: NYNRIN were changed from to Wilms tumour predisposition
Wilms Tumour Predisposition v0.10 NYNRIN Zornitza Stark Classified gene: NYNRIN as Amber List (moderate evidence)
Wilms Tumour Predisposition v0.10 NYNRIN Zornitza Stark Gene: nynrin has been classified as Amber List (Moderate Evidence).
Wilms Tumour Predisposition v0.9 FBXW7 Zornitza Stark Marked gene: FBXW7 as ready
Wilms Tumour Predisposition v0.9 FBXW7 Zornitza Stark Gene: fbxw7 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.9 FBXW7 Zornitza Stark Marked gene: FBXW7 as ready
Wilms Tumour Predisposition v0.9 FBXW7 Zornitza Stark Gene: fbxw7 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.9 FBXW7 Zornitza Stark Phenotypes for gene: FBXW7 were changed from to Wilms tumour
Wilms Tumour Predisposition v0.8 FBXW7 Zornitza Stark Classified gene: FBXW7 as Green List (high evidence)
Wilms Tumour Predisposition v0.8 FBXW7 Zornitza Stark Gene: fbxw7 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.7 NYNRIN Laura Raiti Deleted their comment
Wilms Tumour Predisposition v0.7 NYNRIN Laura Raiti commented on gene: NYNRIN: 3 individuals with Wilms Tumour reported (2 children from 1 family, the 3rd child from a second family).
Biallelic truncating mutations in NYNRIN in three children with Wilms Tumour from two families, each parent was heterozygous for one of the mutations.
One of the affected children had an inguinal hernia and another had epilepsy, hypothyroidism, and intellectual disability.
Wilms Tumour Predisposition v0.7 NYNRIN Laura Raiti gene: NYNRIN was added
gene: NYNRIN was added to Wilms Tumour Predisposition. Sources: Literature
Mode of inheritance for gene: NYNRIN was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: NYNRIN were set to PMID: 30885698
Review for gene: NYNRIN was set to AMBER
Added comment: 3 individuals with Wilms Tumour reported (2 children from 1 family, the 3rd child from a second family).
Biallelic truncating mutations in NYNRIN in three children with Wilms Tumour from two families, each parent was heterozygous for one of the mutations.
One of the affected children had an inguinal hernia and another had epilepsy, hypothyroidism, and intellectual disability.
Sources: Literature
Wilms Tumour Predisposition v0.7 FBXW7 Laura Raiti gene: FBXW7 was added
gene: FBXW7 was added to Wilms Tumour Predisposition. Sources: Literature
Mode of inheritance for gene: FBXW7 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: FBXW7 were set to PMID: 30885698; PMID: 26482194
Review for gene: FBXW7 was set to GREEN
Added comment: PMID: 30885698
4 individuals with germline truncating variants in FBXW7. Highly intolerant to protein-truncating variants with pLI score= 1.
- 1 of these 4 individuals developed a second malignancy (osteosarcoma) as an adult in addition to childhood Wilms tumour.

PMID: 26482194
1 patient with Hodgkin lymphoma, adult Wilms tumour, early-onset breast cancer with a constitutional FBXW7 deletion was reported
Sources: Literature
Wilms Tumour Predisposition v0.7 ASXL1 Zornitza Stark Marked gene: ASXL1 as ready
Wilms Tumour Predisposition v0.7 ASXL1 Zornitza Stark Gene: asxl1 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.7 ASXL1 Zornitza Stark Classified gene: ASXL1 as Green List (high evidence)
Wilms Tumour Predisposition v0.7 ASXL1 Zornitza Stark Gene: asxl1 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.6 ASXL1 Laura Raiti gene: ASXL1 was added
gene: ASXL1 was added to Wilms Tumour Predisposition. Sources: Literature
Mode of inheritance for gene: ASXL1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: ASXL1 were set to PMID: 29446906
Phenotypes for gene: ASXL1 were set to Bohring-Opitz syndrome , MIM#605039
Review for gene: ASXL1 was set to GREEN
Added comment: Isolated case reports suggest that individuals with BOS are at greater risk for Wilms tumor than the general population.
Recommended surveillance: Renal ultrasound every three months from birth to age eight to screen for the development of Wilms tumor; frequent monitoring of growth and development; close monitoring of feeding intolerance with a gastroenterology specialist; regular follow up for vision optimization.
Sources: Literature
Wilms Tumour Predisposition v0.6 Sebastian Lunke Panel name changed from Wilms Tumour Predisposition_VCGS to Wilms Tumour Predisposition
Panel types changed to Victorian Clinical Genetics Services
Wilms Tumour Predisposition v0.5 TRIM28 Zornitza Stark Marked gene: TRIM28 as ready
Wilms Tumour Predisposition v0.5 TRIM28 Zornitza Stark Gene: trim28 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.5 TRIM28 Zornitza Stark Classified gene: TRIM28 as Green List (high evidence)
Wilms Tumour Predisposition v0.5 TRIM28 Zornitza Stark Gene: trim28 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.4 TRIM28 Zornitza Stark gene: TRIM28 was added
gene: TRIM28 was added to Wilms Tumour Predisposition_VCGS. Sources: Literature
Mode of inheritance for gene: TRIM28 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: TRIM28 were set to 30694527
Phenotypes for gene: TRIM28 were set to Wilm's tumour
Review for gene: TRIM28 was set to GREEN
Added comment: Eleven individuals with germline variants identified; plus one somatic. Exome sequencing on eight tumor DNA samples from six individuals showed loss-of-heterozygosity (LOH) of the TRIM28-locus by mitotic recombination in seven tumors, suggesting that TRIM28 functions as a tumor suppressor gene in Wilms tumor development.
Sources: Literature
Wilms Tumour Predisposition v0.3 BRCA2 Zornitza Stark Marked gene: BRCA2 as ready
Wilms Tumour Predisposition v0.3 BRCA2 Zornitza Stark Added comment: Comment when marking as ready: Evidence for WT predisposition in Fanconi anaemia caused by bi-allelic BRCA2 variants. Note only a single family where heterozygous variant reported, so insufficient evidence.
Wilms Tumour Predisposition v0.3 BRCA2 Zornitza Stark Gene: brca2 has been classified as Green List (High Evidence).
Wilms Tumour Predisposition v0.3 BRCA2 Zornitza Stark Publications for gene: BRCA2 were set to
Wilms Tumour Predisposition v0.2 BRCA2 Zornitza Stark Mode of inheritance for gene: BRCA2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
Wilms Tumour Predisposition v0.1 BRCA2 Chris Richmond reviewed gene: BRCA2: Rating: GREEN; Mode of pathogenicity: None; Publications: 15689453, 16857697; Phenotypes: Fanconi anemia, complementation group D1 605724; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Wilms Tumour Predisposition v0.0 TRIM37 Zornitza Stark gene: TRIM37 was added
gene: TRIM37 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: TRIM37 was set to Unknown
Wilms Tumour Predisposition v0.0 PIK3CA Zornitza Stark gene: PIK3CA was added
gene: PIK3CA was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: PIK3CA was set to Unknown
Wilms Tumour Predisposition v0.0 GPC4 Zornitza Stark gene: GPC4 was added
gene: GPC4 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: GPC4 was set to Unknown
Wilms Tumour Predisposition v0.0 DICER1 Zornitza Stark gene: DICER1 was added
gene: DICER1 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: DICER1 was set to Unknown
Wilms Tumour Predisposition v0.0 BLM Zornitza Stark gene: BLM was added
gene: BLM was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: BLM was set to Unknown
Wilms Tumour Predisposition v0.0 CTR9 Zornitza Stark gene: CTR9 was added
gene: CTR9 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: CTR9 was set to Unknown
Wilms Tumour Predisposition v0.0 BUB1B Zornitza Stark gene: BUB1B was added
gene: BUB1B was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: BUB1B was set to Unknown
Wilms Tumour Predisposition v0.0 PALB2 Zornitza Stark gene: PALB2 was added
gene: PALB2 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: PALB2 was set to Unknown
Wilms Tumour Predisposition v0.0 TP53 Zornitza Stark gene: TP53 was added
gene: TP53 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: TP53 was set to Unknown
Wilms Tumour Predisposition v0.0 BRCA2 Zornitza Stark gene: BRCA2 was added
gene: BRCA2 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: BRCA2 was set to Unknown
Wilms Tumour Predisposition v0.0 REST Zornitza Stark gene: REST was added
gene: REST was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: REST was set to Unknown
Wilms Tumour Predisposition v0.0 GPC3 Zornitza Stark gene: GPC3 was added
gene: GPC3 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: GPC3 was set to Unknown
Wilms Tumour Predisposition v0.0 DIS3L2 Zornitza Stark gene: DIS3L2 was added
gene: DIS3L2 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: DIS3L2 was set to Unknown
Wilms Tumour Predisposition v0.0 CDKN1C Zornitza Stark gene: CDKN1C was added
gene: CDKN1C was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: CDKN1C was set to Unknown
Wilms Tumour Predisposition v0.0 CDC73 Zornitza Stark gene: CDC73 was added
gene: CDC73 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: CDC73 was set to Unknown
Wilms Tumour Predisposition v0.0 WT1 Zornitza Stark gene: WT1 was added
gene: WT1 was added to Wilms Tumour Predisposition_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services
Mode of inheritance for gene: WT1 was set to Unknown
Wilms Tumour Predisposition v0.0 Zornitza Stark Added panel Wilms Tumour Predisposition_VCGS